<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Harms JE</submitter><funding>NIA NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><pagination>10702-10714</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4036187</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>289(15)</volume><pubmed_abstract>AMPA receptors are gated through binding of glutamate to a solvent-accessible ligand-binding domain. Upon glutamate binding, these receptors undergo a series of conformational rearrangements regulating channel function. Allosteric modulators can bind within a pocket adjacent to the ligand-binding domain to stabilize specific conformations and prevent desensitization. Yelshansky et al. (Yelshansky, M. V., Sobolevsky, A. I., Jatzke, C., and Wollmuth, L. P. (2004) J. Neurosci. 24, 4728-4736) described a model of an electrostatic interaction between the ligand-binding domain and linker region to the pore that regulated channel desensitization. To test this hypothesis, we have conducted a series of experiments focusing on the R628E mutation. Using ultrafast perfusion with voltage clamp, we appl</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>A charge-inverting mutation in the "linker" region of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors alters agonist binding and gating kinetics independently of allosteric modulators.</pubmed_title><pmcid>PMC4036187</pmcid><funding_grant_id>S11NS055883</funding_grant_id><funding_grant_id>SC1 AG046907</funding_grant_id><funding_grant_id>U54NS083932</funding_grant_id><funding_grant_id>U54 NS060659</funding_grant_id><funding_grant_id>SC1AG046907</funding_grant_id><funding_grant_id>U54 NS083932</funding_grant_id><funding_grant_id>R01 MH064700</funding_grant_id><funding_grant_id>S11 NS055883</funding_grant_id><pubmed_authors>Benveniste M</pubmed_authors><pubmed_authors>Harms JE</pubmed_authors><pubmed_authors>Kessler M</pubmed_authors><pubmed_authors>Stone LM</pubmed_authors><pubmed_authors>Arai AC</pubmed_authors><pubmed_authors>Partin KM</pubmed_authors></additional><is_claimable>false</is_claimable><name>A charge-inverting mutation in the "linker" region of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors alters agonist binding and gating kinetics independently of allosteric modulators.</name><description>AMPA receptors are gated through binding of glutamate to a solvent-accessible ligand-binding domain. Upon glutamate binding, these receptors undergo a series of conformational rearrangements regulating channel function. Allosteric modulators can bind within a pocket adjacent to the ligand-binding domain to stabilize specific conformations and prevent desensitization. Yelshansky et al. (Yelshansky, M. V., Sobolevsky, A. I., Jatzke, C., and Wollmuth, L. P. (2004) J. Neurosci. 24, 4728-4736) described a model of an electrostatic interaction between the ligand-binding domain and linker region to the pore that regulated channel desensitization. To test this hypothesis, we have conducted a series of experiments focusing on the R628E mutation. Using ultrafast perfusion with voltage clamp, we appl</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Apr</publication><modification>2025-04-19T01:11:23.106Z</modification><creation>2019-03-27T01:28:58Z</creation></dates><accession>S-EPMC4036187</accession><cross_references><pubmed>24550387</pubmed><doi>10.1074/jbc.m113.526921</doi><doi>10.1074/jbc.M113.526921</doi></cross_references></HashMap>